SGX rejects Thomson Medical’s application to extend period for public float restoration
The company applied for a further extension on 2 January.
Thomson Medical failed to get approval from the Singapore Exchange to extend the period given to them to restore their public float.
In a bourse filing, the company said it sought another extension from the bourse on 2 January.
The first extension granted by the SGX to Thomson Medical ended on 10 January.
Despite SGX’s rejection of the company’s application, Thomson Medical said trading of its shares on the mainboard will continue.
The company also assured the public that it will continue to explore possible options to restore its public float as soon as possible.